The Australian sharemarket finished higher as most sectors rebounded from a mass selloff on Monday as some fears of a prolonged US-Israel war with Iran and elevated oil and gas prices subsided.

BioNTech on track for a catalyst-rich year with six late-stage data readouts expected across immunomodulators, antibody-drug conjugates and mRNA cancer immunotherapies Increased focus on PD-L1 1 /VEGF ...

BioNTech on track for a catalyst-rich year with six late-stage data readouts expected across immunomodulators, antibody-drug conjugates and mRNA cancer immunotherapies MAINZ, Germany, March 10, 2026 ...